0001708138-21-000020.txt : 20210518
0001708138-21-000020.hdr.sgml : 20210518
20210518160414
ACCESSION NUMBER: 0001708138-21-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210514
FILED AS OF DATE: 20210518
DATE AS OF CHANGE: 20210518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAHL NEIL
CENTRAL INDEX KEY: 0001226689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 21935943
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-05-14
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001226689
STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Research and Development
Common Stock
2021-02-25
5
G
0
435
0.0
D
24280
D
Common Stock
2021-05-14
4
M
0
40000
179.13
A
64280
D
Common Stock
2021-05-14
4
F
0
27775
516.69
D
36505
D
Common Stock
2021-05-14
4
M
0
12500
52.03
A
49005
D
Common Stock
2021-05-14
4
F
0
7204
516.69
D
41801
D
Common Stock
2021-05-17
4
S
0
3379
518.63
D
38422
D
Common Stock
2021-05-17
4
S
0
10336
519.47
D
28086
D
Common Stock
2021-05-17
4
S
0
3806
520.17
D
24280
D
Common Stock
5787
I
By 401(k) Plan
Common Stock
9134
I
by 2019 GRAT
Non-Qualified Stock Option (right to buy)
52.03
2021-05-14
4
M
0
12500
0.0
D
2021-12-16
Common Stock
12500
0
D
Non-Qualified Stock Option (right to buy)
179.13
2021-05-14
4
M
0
40000
0.0
D
2022-12-14
Common Stock
40000
72500
D
Represents volume-weighted average price of sales of 3,379 shares of Company stock on May 17, 2021 at prices ranging from $518.02 to $518.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price.
Represents volume-weighted average price of sales of 10,336 shares of Company stock on May 17, 2021 at prices ranging from $519.00 to $519.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price.
Represents volume-weighted average price of sales of 3,806 shares of Company stock on May 17, 2021 at prices ranging from $520.02 to $520.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price.
The option became exercisable on December 31, 2014, based upon the satisfaction by the Company of certain performance criteria during the period ended December 31, 2014.
The stock option award vested in four equal annual installments, commencing one year after the date of grant.
/s/**Neil Stahl
2021-05-18